Growth Metrics

Travere Therapeutics (TVTX) Cash & Equivalents (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -15.77%
Dec 31, 2025 -16.13%
Sep 30, 2025 47.60%
Jun 30, 2025 21.42%
Mar 31, 2025 5.74%
Dec 31, 2024 60.77%
Sep 30, 2024 12.75%
Jun 30, 2024 -25.34%
Mar 31, 2024 -25.65%
Dec 31, 2023 -59.67%
Sep 30, 2023 103.52%
Jun 30, 2023 -56.08%
Mar 31, 2023 161.60%
Dec 31, 2022 -59.24%
Sep 30, 2022 -15.81%
Jun 30, 2022 -29.94%
Mar 31, 2022 54.79%
Dec 31, 2021 10.26%
Sep 30, 2021 80.49%
Jun 30, 2021 -43.81%
Mar 31, 2021 74.86%
Dec 31, 2020 -57.72%
Sep 30, 2020 -15.47%
Jun 30, 2020 253.88%
Mar 31, 2020 7.34%
Dec 31, 2019 -4.22%
Sep 30, 2019 -13.84%
Jun 30, 2019 8.33%
Mar 31, 2019 -32.11%
Dec 31, 2018 -33.55%
Sep 30, 2018 73.36%
Jun 30, 2018 46.12%
Mar 31, 2018 -38.51%
Dec 31, 2017 0.41%
Sep 30, 2017 10.89%
Jun 30, 2017 113.20%
Mar 31, 2017 2.12%
Dec 31, 2016 71.59%
Sep 30, 2016 12.95%
Jun 30, 2016 -9.06%
Mar 31, 2016 -38.47%
Dec 31, 2015 -73.11%
Sep 30, 2015 10.06%
Jun 30, 2015 6.30%
Mar 31, 2015 560.16%
Dec 31, 2014 -29.61%
Sep 30, 2014 -35.15%
Jun 30, 2014 979.16%
Mar 31, 2014 -38.38%
Dec 31, 2013 -55.28%